Anti-Cytokeratin 7 antibody [EPR1619Y] - Cytoskeleton Marker,Abcam,AB68459

What is this antibody validated in? Anti-Cytokeratin 7 antibody [EPR1619Y] - Cytoskeleton Marker (ab68459) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human samples. What is the molecular weight of Cytokeratin 7? Anti-Cytokeratin 7 [EPR1619Y] - Cytoskeleton Marker (ab68459) specifically detects a band for Cytokeratin 7 (UniProt: P08729) at a molecular weight of 51kDa. Trusted by the scientific community Anti-Cytokeratin 7 [EPR1619Y] - Cytoskeleton Marker (ab68459) was first used in a scientific publication in 2008 and has been cited over 30 times in peer-reviewed journals. Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies. Specificity confirmed The specificity of Anti-Cytokeratin 7 antibody [EPR1619Y] - Cytoskeleton Marker (ab68459) has been confirmed by Western blot testing in KRT7 Knockout A549 cells. Other related products We have a range of other formats of antibody clone [EPR1619Y] also available for your convenience: ab68459, Carrier free - ab181831 , Alexa Fluor® 488 - ab185048 , Alexa Fluor® 647 - ab192077 , HRP - ab192079 , Alexa Fluor® 594 - ab203427 , Alexa Fluor® 555 - ab203434 , PE - ab210628 , Carrier free - ab302460 Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .